Granville Matheson

Publications
Grants
CV
Public outreach and news

Articles

Journal article: IMAGING NEUROSCIENCE. 2024;2:1-16
PET imaging of the serotonin 1A receptor in major depressive disorder: Hierarchical multivariate analysis of [11C]WAY100635 overcomes outcome measure discrepancies
Matheson GJ; Zanderigo F; Miller JM; Bartlett EA; Mann JJ; Ogden RT
Article: JOURNAL OF OPEN SOURCE SOFTWARE. 2024;9(100):6067
PET2BIDS: a library for converting Positron Emission Tomography data to BIDS.
Galassi A; Norgaard M; Thomas AG; Gonzalez-Escamilla G; Svarer C; Rorden C; Matheson GJ; Knudsen GM; Innis RB; Ganz M; Eierud C; Bilgel M; Pernet C
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2024;27(5):pyae021
Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect
Garde M; Matheson GJ; Varnaes K; Svenningsson P; Hedman-Lagerloef E; Lundberg J; Farde L; Tiger M
Article: IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING. 2024;71(4):1191-1196
Nonlinear Mixed-Effects Modeling Approach for Simplified Reference Tissue Model
Shieh D; Matheson GJ; Ogden RT
Article: EJNMMI PHYSICS. 2023;10(1):72
Parametric and non-parametric Poisson regression for modelling of the arterial input function in positron emission tomography
Matheson GJ; Ge L; Zhang M; Sun B; Tu Y; Zanderigo F; Moren AF; Ogden RT
Article: ADDICTION. 2023;118(6):1053-1061
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers
Jangard S; Jayaram-Lindstrom N; Isacsson NH; Matheson GJ; Plaven-Sigray P; Franck J; Borg J; Farde L; Cervenka S
Article: EJNMMI PHYSICS. 2023;10(1):17
Multivariate analysis of PET pharmacokinetic parameters improves inferential efficiency
Matheson GJJ; Ogden RT
Article: BRAIN SCIENCES. 2022;12(10):1338
Experimental Sleep Deprivation Results in Diminished Perceptual Stability Independently of Psychosis Proneness
Balter LJT; Matheson GJ; Sundelin T; Sterzer P; Petrovic P; Axelsson J
Article: NEUROIMAGE. 2022;256:119195
Simultaneous multifactor Bayesian analysis (SiMBA) of PET time activity curve data
Matheson GJ; Ogden RT
Article: THE LANCET PSYCHIATRY. 2022;9(6):447-457
Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in Sweden
Millischer V; Matheson GJ; Bergen SE; Coombes BJ; Ponzer K; Wikstrom F; Jagiello K; Lundberg M; Stenvinkel P; Biernacka JM; Breuer O; Martinsson L; Landen M; Backlund L; Lavebratt C; Schalling M
Article: SCIENTIFIC DATA. 2022;9(1):65
PET-BIDS, an extension to the brain imaging data structure for positron emission tomography
Norgaard M; Matheson GJ; Hansen HD; Thomas A; Searle G; Rizzo G; Veronese M; Giacomel A; Yaqub M; Tonietto M; Funck T; Gillman A; Boniface H; Routier A; Dalenberg JR; Betthauser T; Feingold F; Markiewicz CJ; Gorgolewski KJ; Blair RW; Appelhoff S; Gau R; Salo T; Niso G; Pernet C; Phillips C; Oostenveld R; Gallezot J-D; Carson RE; Knudsen GM; Innis RB; Ganz M
Article: MOLECULAR PSYCHIATRY. 2022;27(2):1233-1240
Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis
Plaven-Sigray P; Ikonen Victorsson P; Santillo A; Matheson GJ; Lee M; Collste K; Fatouros-Bergman H; Sellgren CM; Erhardt S; Agartz I; Halldin C; Farde L; Cervenka S
Article: HEPATOLOGY. 2021;74(6):3301-3315
Test-Retest Reliability and Consistency of HVPG and Impact on Trial Design: A Study in 289 Patients from 20 Randomized Controlled Trials
Bai W; Al-Karaghouli M; Stach J; Sung S; Matheson GJ; Abraldes JG
Article: JOURNAL OF AFFECTIVE DISORDERS. 2021;294:645-651
A positron emission tomography study of the serotonin1B receptor effect of electroconvulsive therapy for severe major depressive episodes
Tiger M; Garde M; Tateno A; Matheson GJ; Sakayori T; Nogami T; Moriya H; Varnas K; Arakawa R; Okubo Y
Article: NEUROIMAGE. 2021;226:117523
Low convergent validity of [¹¹C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [¹¹C]FLB 457
Freiburghaus T; Svensson JE; Matheson GJ; Plaven-Sigray P; Lundberg J; Farde L; Cervenka S
Article: EJNMMI RESEARCH. 2020;10(1):95
Reliability of dopamine transporter PET measurements with [¹⁸F]FE-PE2I in patients with Parkinson's disease
Kerstens VS; Fazio P; Sundgren M; Matheson GJ; Franzen E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Article: SCHIZOPHRENIA RESEARCH. 2020;222:175-184
Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness
Matheson GJ; Plaven-Sigray P; Louzolo A; Borg J; Farde L; Petrovic P; Cervenka S
Article: EJNMMI RESEARCH. 2020;10(1):77
Kinfitr - an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability
Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Journal article: SCHIZOPHRENIA BULLETIN. 2020;46(Supplement_1):s135-s136
M7. LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS – A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY
Victorsson P; Plavén-Sigray P; Matheson G; Santillo A; Lee M; Collste K; Fatouros-Bergman H; Agartz I; Halldin C; Farde L; Cervenka S
Journal article: SCHIZOPHRENIA BULLETIN. 2020;46(Supplement_1):s233
T7. UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS
Plavén-Sigray P; Matheson G; Coughlin J; Hafizi S; Laurikainen H; Ottoy J; de’Picker L; Rusjan P; Hietala J; Howes O; Mizrahi R; Morrens M; Pomper M; Cervenka S
Article: PSYCHIATRY RESEARCH. 2020;284:112677
AKT1 and genetic vulnerability to bipolar disorder
Millischer V; Matheson GJ; Martinsson L; Ek IR; Schalling M; Lavebratt C; Backlund L
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2019;22(7):415-425
D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients
Stenkrona P; Matheson GJ; Halldin C; Cervenka S; Farde L
Article: PEERJ. 2019;7:e6918
We need to talk about reliability: making better use of test-retest studies for study design and interpretation
Matheson GJ
Article: EJNMMI RESEARCH. 2018;8(1):102
Test-retest reliability and convergent validity of (R)-[¹¹C]PK11195 outcome measures without arterial input function
Plaven-Sigray P; Matheson GJ; Cselenyi Z; Jucaite A; Farde L; Cervenka S
Article: BIOLOGICAL PSYCHIATRY. 2018;84(6):433-442
Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data
Plaven-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
Article: EJNMMI RESEARCH. 2018;8(1):74
[¹¹C]SCH23390 binding to the D₁-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis
Stenkrona P; Matheson GJ; Cervenka S; Sigray PP; Halldin C; Farde L
Article: PEERJ. 2018;6:e5790
Serotonin 5-HT₁_A receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing
Griffioen G; Matheson GJ; Cervenka S; Farde L; Borg J
Article: PLOS ONE. 2018;13(12):e0209584
Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men
Caravaggio F; Plaven-Sigray P; Matheson GJ; Plitman E; Chakravarty MM; Borg J; Graff-Guerrero A; Cervenka S
Article: PLOS ONE. 2018;13(3):e0193770
Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
Plaven-Sigray P; Matheson GJ; Gustavsson P; Stenkrona P; Halldin C; Farde L; Cervenka S
Article: EJNMMI RESEARCH. 2017;7(1):58
Assessment of simplified ratio-based approaches for quantification of PET [¹¹C] PBR28 data
Matheson GJ; Plaven-Sigray P; Forsberg A; Varrone A; Farde L; Cervenka S
Article: ELIFE. 2017;6:e27725
The readability of scientific texts is decreasing over time
Plaven-Sigray P; Matheson GJ; Schiffler BC; Thompson WH
Article: NEUROIMAGE. 2017;155:344-353
Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [¹¹C] SCH-23390
Matheson GJ; Stenkrona P; Cselenyi Z; Plaven-Sigray P; Halldin C; Farde L; Cervenka S
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27(5):462-469
Extrastriatal dopamine D2-receptor availability in social anxiety disorder
Plaven-Sigray P; Hedman E; Victorsson P; Matheson GJ; Forsberg A; Djurfeldt DR; Ruck C; Halldin C; Lindefors N; Cervenka S
Article: MOLECULAR PSYCHIATRY. 2016;21(8):1077-1084
Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain
Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jonsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
Article: NEUROIMAGE. 2015;112:225-231
Diurnal and seasonal variation of the brain serotonin system in healthy male subjects
Matheson GJ; Schain M; Almeida R; Lundberg J; Cselenyi Z; Borg J; Varrone A; Farde L; Cervenka S
Show more

All other publications

Preprint: MEDRXIV. 2024
Trajectories of Cognitive Function in First-Episode Psychosis: Associations to Clinical Outcomes and Biomarkers
Lee M; Cullen AE; Matheson GJ; Lu Z-A; Bergen SE; Sellgren CM; Erhardt S; Fatouros-Bergman H; Cervenka S
Preprint: BIORXIV. 2024;BIORXIV
PET Imaging of the Serotonin 1A Receptor in Major Depressive Disorder: Hierarchical Multivariate Analysis of [11C]WAY100635 Overcomes Outcome Measure Discrepancies.
Matheson GJ; Zanderigo F; Miller JM; Bartlett EA; Mann JJ; Ogden RT
Preprint: BIORXIV. 2022
Multivariate Analysis of PET Pharmacokinetic Parameters
Matheson G; Ogden T
Preprint: BIORXIV. 2021
PET-BIDS, an extension to the brain imaging data structure for positron emission tomography
Norgaard M; Matheson G; Hansen H; Thomas A; Searle G; Rizzo G; Veronese M; Giacomel A; Yaqub M; Tonietto M; Funck T; Gillman A; Boniface H; Routier A; Dalenberg J; Betthauser T; Feingold F; Markiewicz C; Gorgolewski K; Blair R; Appelhoff S; Gau R; Salo T; Niso G; Pernet C; Phillips C; Oostenveld R; Gallezot J-D; Carson R; Knudsen G; Innis R; Ganz M
Letter: BIOLOGICAL PSYCHIATRY. 2021;89(3):e5-e8
Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences
Plaven-Sigray P; Matheson GJ; Coughlin JM; Hafizi S; Laurikainen H; Ottoy J; De Picker L; Rusjan P; Hietala J; Howes OD; Mizrahi R; Morrens M; Pomper MG; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):117-119
The positron emission tomography brain imaging data structure (PET-BIDS) extension: A new standard for sharing PET data
Norgaard M; Matheson GJ; Hansen HD; Thomas A; Searle G; Rizzo G; Veronese M; Giacomel A; Yaqub M; Tonietto M; Funck T; Gillman A; Boniface H; Routier A; Dalenberg JR; Betthauser T; Feingold F; Markiewicz CJ; Gorgolewski KJ; Blair RW; Appelhoff S; Gau R; Salo T; Niso G; Pernet C; Phillips C; Oostenveld R; Gallezot J-D; Carson RE; Knudsen GM; Innis RB; Ganz M
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):224-225
Strength in numbers: Multilevel modelling of time activity curves
Matheson GJ; Chen Y; Zanderigo F; Ogden RT
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):131-132
Assessing neurobiological correlates of [¹¹C]WAY-100635 two-tissue compartment model parameters using SiMBA
Matheson GJ; Ogden RT
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):121-122
Simultaneous Multifactor Bayesian Analysis (SiMBA) of PET Time Activity Curve Data
Matheson GJ; Ogden RT
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):260-261
Lower thalamic dopamine D2-receptor binding and connectivity in drug-naive patients with psychosis - A combined [11C]FLB 457 PET and DTI study
Victorsson P; Plaven-Sigray P; Santillo A; Matheson GJ; Lee M; Collste K; Fatouros-Bergman H; Agartz I; Halldin C; Farde L; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):228-229
Meta-analysis of the glial marker TSPO in psychosis revisited: Reconciling inconclusive findings of patient-control differences
Plaven-Sigray P; Matheson GJ; Coughlin JM; Hafizi S; Laurikainen H; Ottoy J; de'Picker L; Rusjan PM; Hietala J; Howes OD; Mizrahi R; Morrens M; Pomper MG; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(1_SUPPL):258-260
Validation of kinfitr: An open-source tool for reproducible PET kinetic modelling
Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Preprint: MEDRXIV. 2020
Test-retest reliability of hepatic venous pressure gradient and impact on trial design: a study in 289 patients from the control groups of 20 randomized trials
Bai W; Al-Karaghouli M; Stach J; Matheson GJ; Abraldes JG
Review: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2020;40(8):1576-1585
Guidelines for the content and format of PET brain data in publications and archives: A consensus paper
Knudsen GM; Ganz M; Appelhoff S; Boellaard R; Bormans G; Carson RE; Catana C; Doudet D; Gee AD; Greve DN; Gunn RN; Halldin C; Herscovitch P; Huang H; Keller SH; Lammertsma AA; Lanzenberger R; Liow J-S; Lohith TG; Lubberink M; Lyoo CH; Mann JJ; Matheson GJ; Nichols TE; Norgaard M; Ogden T; Parsey R; Pike VW; Price J; Rizzo G; Rosa-Neto P; Schain M; Scott PJH; Searle G; Slifstein M; Suhara T; Talbot PS; Thomas A; Veronese M; Wong DF; Yaqub M; Zanderigo F; Zoghbi S; Innis RB
Preprint: RESEARCH SQUARE. 2020
Reliability of Dopamine Transporter PET Measurements with [18F]FE-PE2I in patients with Parkinson´s Disease
Kerstens V; Fazio P; Sundgren M; Matheson G; Franzén E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Preprint: BIORXIV. 2020
Low convergent validity of [₁₁C]raclopride binding in extrastriatal brain regions: a PET study of within-subject correlations with [₁₁C]FLB 457
Freiburghaus T; Svensson J; Matheson G; Plavén-Sigray P; Lundberg J; Farde L; Cervenka S
Preprint: RESEARCH SQUARE. 2020
Reliability of Dopamine Transporter PET Measurements with [18F]FE-PE2I in patients with Parkinson's Disease
Kerstens VS; Fazio P; Sundgren M; Matheson GJ; Franzén E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Preprint: BIORXIV. 2020
Kinfitr – an open source tool for reproducible PET modelling: validation and evaluation of test-retest reliability
Tjerkaski J; Cervenka S; Farde L; Matheson GJ
Letter: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2020;47(2):502-504
Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise
Matheson GJ; Plaven-Sigray P; Tuisku J; Rinne J; Matuskey D; Cervenka S
Conference publication: HEPATOLOGY. 2020;72:72A
TEST-RETEST RELIABILITY OF HEPATIC VENOUS PRESSURE GRADIENT IN 289 PATIENTS FROM THE CONTROL GROUPS OF 20 RANDOMIZED CONTROLLED TRIALS. IMPACT ON TRIAL DESIGN.
Bai W; Al-Karaghouli M; Stach J; Matheson G; Abraldes JG
Conference publication: SCHIZOPHRENIA BULLETIN. 2020;46:S135-S136
LOWER THALAMIC DOPAMINE D2-RECEPTOR BINDING IN DRUG-NAIVE PATIENTS WITH PSYCHOSIS - A REPLICATION STUDY USING POSITRON EMISSION TOMOGRAPHY
Victorsson P; Plaven-Sigray P; Matheson G; Santillo A; Lee M; Collste K; Fatouros-Bergman H; Agartz I; Halldin C; Farde L; Cervenka S
Conference publication: SCHIZOPHRENIA BULLETIN. 2020;46:S233
UPDATED INDIVIDUAL PARTICIPANT DATA META-ANALYSIS CONFIRMS LOWER LEVELS OF THE GLIAL MARKER TSPO IN PSYCHOSIS PATIENTS
Plaven-Sigray P; Matheson G; Coughlin J; Hafizi S; Laurikainen H; Ottoy J; de'Picker L; Rusjan P; Hietala J; Howes O; Mizrahi R; Morrens M; Pomper M; Cervenka S
Preprint: BIORXIV. 2019
kinfitr: Reproducible PET Pharmacokinetic Modelling in R
Matheson G
Conference publication: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2019;46(SUPPL 1):S392-S393
Reliability of Dopamine Transporter PET Measurements with [¹⁸F]FE-PE2I in Early Stage Parkinson's Disease: A Preliminary Test-Retest Evaluation
Kerstens V; Fazio P; Sundgren M; Matheson GJ; Franzen E; Halldin C; Cervenka S; Svenningsson P; Varrone A
Thesis / dissertation: 2018
Reliability, replicability and reproducibility in PET imaging
Matheson, Granville James
Preprint: BIORXIV. 2018
Dopamine D1 receptor availability is not associated with delusional ideation measures of psychosis proneness
Matheson GJ; Plavén-Sigray P; Louzolo A; Borg J; Farde L; Petrovic P; Cervenka S
Preprint: BIORXIV. 2018
Test-retest reliability and convergent validity of (R)-[¹¹C]PK11195 outcome measures without arterial input function
Plavén-Sigray P; Matheson GJ; Cselényi Z; Jučaite A; Farde L; Cervenka S
Preprint: BIORXIV. 2018
We need to talk about reliability: Making better use of test-retest studies for study design and interpretation
Matheson G
Dataset: 2018
nls.multstart: Robust Non-Linear Regression using AIC Scores
Padfield D; Matheson G
Dataset: 2018
staplr: A Toolkit for PDF Files
Talagala PD; Mancarci O; Padfield D; Matheson G; Vinyals M
Preprint: BIORXIV. 2017
PET studies of the glial cell marker TSPO in psychosis patients - a meta-analysis using individual participant data
Plavén-Sigray P; Matheson G; Collste K; Ashok A; Coughlin J; Howes O; Mizrahi R; Pomper M; Rusjan P; Veronese M; Wang Y; Cervenka S
Preprint: BIORXIV. 2017
Serotonin 5-HT_1A receptor binding and self-transcendence in healthy control subjects - a replication study using Bayesian hypothesis testing
Griffioen G; Matheson GJ; Cervenka S; Farde L; Borg J
Preprint: BIORXIV. 2017
Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study
Plavén-Sigray P; Matheson GJ; Gustavsson P; Stenkrona P; Halldin C; Farde L; Cervenka S
Preprint: BIORXIV. 2017
The readability of scientific texts is decreasing over time
Plavén-Sigray P; Matheson GJ; Schiffler BC; Thompson WH
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37:237
Serotonin 5HT_1A receptor binding and self-transcendence in healthy control subjects - a replication study using Bayesian inference
Griffioen G; Borg J; Matheson GJ; Cervenka S; Farde L
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2017;37:165-166
Assessment of the reliability and validity of simplified ratio-based quantification approaches for [¹¹C]PBR28
Matheson GJ; Sigray PP; Forsberg A; Collste K; Varrone A; Halldin C; Farde L; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:677-678
ELEVATED LEVELS OF ORBITOFRONTAL DOPAMINE D2-RECEPTORS IN PATIENTS WITH SOCIAL ANXIETY DISORDER
Sigray PP; Hedman E; Ikonen P; Matheson G; Forsberg A; Djurfeldt D; Ruck C; Halldin C; Lindefors N; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:674-675
ASSESSING THE DOPAMINERGIC BASIS OF DELUSIONAL IDEATION: THE RELATIONSHIP BETWEEN D1 AND D2 RECEPTOR AVAILABILITY AND DELUSIONAL BELIEFS IN HEALTHY SUBJECTS
Matheson GJ; Louzolo A; Plaven-Sigray P; Stenkrona P; Farde L; Ingvar M; Petrovic P; Cervenka S
Conference publication: INTERNATIONAL JOURNAL OF PSYCHOLOGY. 2016;51:879
Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain
Borg J; Cervenka S; Kuja-Halkola R; Matheson GJ; Jonsson EG; Lichtenstein P; Henningsson S; Ichimiya T; Larsson H; Stenkrona P; Halldin C; Farde L
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:675-676
DIURNAL AND SEASONAL VARIATION OF THE BRAIN SEROTONIN SYSTEM IN HEALTHY MALE SUBJECTS
Matheson GJ; Schain M; Almeida R; Lundberg J; Cselenyi Z; Borg J; Varrone A; Farde L; Cervenka S
Conference publication: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2016;36:676
PET STUDY OF THALAMIC DOPAMINE D2-RECEPTORS IN DRUG-NAIVE PATIENTS WITH SCHIZOPHRENIA
Ikonen P; Cervenka S; Collste K; Fatouros-Bergman H; Matheson G; Sigray PP; Varrone A; Halldin C; Flyckt L; Farde L
Show more

Grants

A new approach for PET quantification using multilevel Bayesian modelling, and its application to study the neurobiology of depression
Swedish Research Council
1 January 2021 - 31 December 2023

Employments

Assistant Professor, Department of Clinical Neuroscience, Karolinska Institutet, 2025-2030
Postdoctoral Researcher, Department of Clinical Neuroscience, Karolinska Institutet, 2022-2024

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2019

Articles

All other publications

Grants

Employments

Degrees and Education

News from KI

Events from KI